Researchers at the San Carlos Clinical Hospital in Madrid have made a promising advancement in the treatment of androgenetic alopecia, commonly known as male- or female-pattern baldness, by utilizing adipose-derived stem cells (ASCs) in combination with adenosine triphosphate (ATP) molecules. The study, published in the journal Stem Cell Research & Therapy, involved injecting mice with these stem cells and observed significant hair regrowth in both male and female subjects when the right dosages were used. The lead study author, Dr. Eduardo López Bran, highlighted the remarkable results, stating that the success rate surpassed expectations. With appropriate dosages, the researchers observed 100% hair regrowth in male mice and up to 90% in female mice.
Scientists at the San Carlos Clinical Hospital in Madrid have identified a potential breakthrough in treating androgenetic alopecia using adipose-derived stem cells (ASCs) combined with ATP molecules, showing impressive hair regrowth results in preclinical trials. The study, published in the journal Stem Cell Research & Therapy, involved injecting mice with these stem cells, which have the potential to regenerate hair follicles. The research team found that male mice achieved the best hair regrowth after three weeks when administered low-dose ASCs, combined with ATP.
The study also noted that female mice showed significant hair regrowth when treated with medium-dose ASCs alongside ATP, although high-dose treatments did not yield improvements. The lead author, Dr. Eduardo López Bran, a dermatologist and professor at the Complutense University of Madrid, emphasized the significance of the findings, stating that the results exceeded expectations.